Benchmark Reiterates Speculative Buy on CytoMed Therapeutics, Maintains $5 Price Target
BenzingaDec 4, 2023 08:57
CytoMed Therapeutics Analyst Ratings
BenzingaDec 4, 2023 08:56
BenzingaJul 21, 2023 05:50
No Data